Orchid Pharma Standalone December 2018 Net Sales at Rs 148.45 crore, up 2.92% Y-o-Y

February 13, 2019 / 02:44 PM IST

live

bselive
nselive

Volume

Todays L/H

Reported Standalone quarterly numbers for Orchid Pharma are:

Net Sales at Rs 148.45 crore in December 2018 up 2.92% from Rs. 144.24 crore in December 2017.

Quarterly Net Loss at Rs. 18.47 crore in December 2018 up 76.08% from Rs. 77.23 crore in December 2017.

EBITDA stands at Rs. 14.40 crore in December 2018 down 34.4% from Rs. 21.95 crore in December 2017.

Orchid Pharma shares closed at 3.30 on February 12, 2019 (NSE) and has given -58.75% returns over the last 6 months and -81.09% over the last 12 months.

Orchid Pharma
Standalone Quarterly Results	in Rs. Cr.

	Dec'18	Sep'18	Dec'17
Net Sales/Income from operations	148.45	142.48	144.24
Other Operating Income	--	--	--
Total Income From Operations	148.45	142.48	144.24
EXPENDITURE
Consumption of Raw Materials	70.63	70.45	63.29
Purchase of Traded Goods	0.08	0.10	0.34
Increase/Decrease in Stocks	0.00	-10.86	-0.23
Power & Fuel	--	--	--
Employees Cost	18.79	19.49	19.54
Depreciation	32.84	32.96	33.48
Excise Duty	--	--	--
Admin. And Selling Expenses	--	--	--
R & D Expenses	--	--	--
Provisions And Contingencies	--	--	--
Exp. Capitalised	--	--	--
Other Expenses	46.45	66.54	47.71
P/L Before Other Inc. , Int., Excpt. Items & Tax	-20.33	-36.19	-19.89
Other Income	1.90	6.28	8.36
P/L Before Int., Excpt. Items & Tax	-18.44	-29.91	-11.53
Interest	0.03	--	76.18
P/L Before Exceptional Items & Tax	-18.47	-29.91	-87.70
Exceptional Items	--	6.78	--
P/L Before Tax	-18.47	-23.13	-87.70
Tax	--	-0.01	-10.47
P/L After Tax from Ordinary Activities	-18.47	-23.13	-77.23
Prior Year Adjustments	--	--	--
Extra Ordinary Items	--	--	--
Net Profit/(Loss) For the Period	-18.47	-23.13	-77.23
Equity Share Capital	88.96	88.96	88.96
Reserves Excluding Revaluation Reserves	--	--	--
Equity Dividend Rate (%)	--	--	--
EPS Before Extra Ordinary
Basic EPS	-2.08	-2.60	-8.68
Diluted EPS	-2.08	-2.60	-8.68
EPS After Extra Ordinary
Basic EPS	-2.08	-2.60	-8.68
Diluted EPS	-2.08	-2.60	-8.68
Public Share Holding
No Of Shares (Crores)	--	--	--
Share Holding (%)	--	--	--
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--
b) Non-encumbered
- Number of shares (Crores)	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--
Source : Dion Global Solutions Limited